Thursday, September 19, 2024
Home Tags Cannabinoid pharmaceutical R&D

Tag: cannabinoid pharmaceutical R&D

AusCann raises A$33.4m via share placement 

ASX-listed medical marijuana company AusCann has successfully raised A$33.4 million via a share placement to institutional and sophisticated investors from North America and Australia, including...
Advertisement

DAAN MMA

WA White Goods

Featured Article

Reality check: Aussie factories’ journey to responsible AI implementation

Artificial intelligence has become more than just a buzzword as it promises to revolutionise every other industry in the world, including manufacturing. In Australia, in particular, the hype surrounding AI and automation has reached a fever pitch, with many business leaders leveraging their resources to race towards adoption and implementation.